A detailed history of Vident Advisory, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Vident Advisory, LLC holds 11,371 shares of TECH stock, worth $829,855. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,371
Previous 12,087 5.92%
Holding current value
$829,855
Previous $866 Million 4.95%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$70.96 - $82.35 $50,807 - $58,962
-716 Reduced 5.92%
11,371 $909 Million
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $2,546 - $3,450
-41 Reduced 0.34%
12,087 $866 Million
Q1 2024

May 14, 2024

BUY
$65.98 - $77.09 $220,571 - $257,711
3,343 Added 38.05%
12,128 $854 Million
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $20,973 - $31,053
-397 Reduced 4.32%
8,785 $678 Million
Q3 2023

Feb 21, 2024

BUY
$67.52 - $89.42 $26,805 - $35,499
397 Added 4.52%
9,182 $625 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $619,968 - $821,054
9,182 New
9,182 $625 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.